{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:05:54Z","timestamp":1789445154550,"version":"build-2803163510"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The pathogenesis of immune thrombocytopenia (ITP) involves platelet destruction driven by immune dysregulation, notably macrophage dysfunction. Lysophosphatidylcholine (LPC), a class of bioactive lipid, can modulate inflammation and immunity. This study aimed to determine whether LPC (16:0\/0:0) reprograms macrophage metabolism and function in ITP, and to evaluate the therapeutic efficacy of dexamethasone (DXM) and atorvastatin (AT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Bone marrow (BM) samples were collected from 61 patients with ITP and 46 healthy controls (HCs) at Qilu Hospital of Shandong University between July 2023 and June 2025. Flow cytometry was used to assess macrophage subsets. Untargeted metabolomics and transcriptomics were performed on sorted BM macrophages. The\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      effects of LPC (16:0\/0:0) on interleukin-10 (IL-10) expression, phagocytosis, and T-cell differentiation, as well as the impact of DXM, AT, or their combination, were tested. Passive and active ITP murine models were used for\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      ITP patients had significantly elevated M1 macrophages and decreased IL-10 levels compared to HCs. Integrated metabolomic and transcriptomic analyses revealed enrichment in the glycerophospholipid metabolism pathway, identifying LPC (16:0\/0:0) as the most significantly elevated metabolite. Elevated LPC (16:0\/0:0) levels correlated with severe thrombocytopenia.\n                      <jats:italic toggle=\"yes\">In vitro<\/jats:italic>\n                      , LPC (16:0\/0:0) suppressed IL-10 secretion by macrophages and enhanced M1 macrophage phagocytosis of platelets. It also reduced regulatory T cells (Treg) proportions and increased helper T cell (Th) 1, Th2 and Th22 differentiation. Treatment with DXM or AT restored IL-10 levels and inhibited phagocytosis; DXM suppressed Th1 and Th2 differentiation, AT restored Treg proportions.\n                      <jats:italic toggle=\"yes\">In vivo<\/jats:italic>\n                      , LPC (16:0\/0:0) decreased platelet counts and promoted M1 macrophage polarization. DXM and AT promoted platelet recovery and macrophage repolarization, with combination therapy demonstrating superior efficacy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>LPC (16:0\/0:0) drives ITP pathogenesis by reprogramming macrophage metabolism and function, promoting inflammation and platelet destruction. The DXM\u2013AT combination exerts synergistic therapeutic effects by complementary targeting of metabolic and immune pathways in the LPC-driven pathogenic axis, effectively restoring immune homeostasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000004172","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:00:10Z","timestamp":1789372810000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Lysophosphatidylcholine-induced macrophage polarization imbalance and functional dysregulation in immune thrombocytopenia"],"prefix":"10.1097","author":[{"given":"Nan","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"},{"name":"Shandong Key Laboratory of Hematological Diseases and Immune Microenvironment, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqiu","family":"Leng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Ayala","family":"Diaz","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre, Madrid 28041, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre, Madrid 28041, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Hu","sequence":"additional","affiliation":[{"name":"Shandong Key Laboratory of Hematological Diseases and Immune Microenvironment, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"},{"name":"Shandong Key Laboratory of Hematological Diseases and Immune Microenvironment, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"},{"name":"Shandong Key Laboratory of Hematological Diseases and Immune Microenvironment, Jinan, Shandong 250012, China"},{"name":"State Key Laboratory for Innovation and Transformation of Luobing Theory, Jinan, Shandong 250012, China"},{"name":"Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Jinan, Shandong 250012, China"},{"name":"Department of Cardiology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"},{"name":"Shandong Key Laboratory of Hematological Diseases and Immune Microenvironment, Jinan, Shandong 250012, China"},{"name":"State Key Laboratory for Innovation and Transformation of Luobing Theory, Jinan, Shandong 250012, China"},{"name":"Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Jinan, Shandong 250012, China"},{"name":"Department of Cardiology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"},{"name":"Shandong Key Laboratory of Hematological Diseases and Immune Microenvironment, Jinan, Shandong 250012, China"},{"name":"State Key Laboratory for Innovation and Transformation of Luobing Theory, Jinan, Shandong 250012, China"},{"name":"Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Jinan, Shandong 250012, China"},{"name":"Department of Cardiology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune Thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N Engl J Med"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-023-01401-z","article-title":"How we treat primary immune thrombocytopenia in adults","volume":"16","author":"Liu","year":"2023","journal-title":"J Hematol Oncol"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R6-20260915","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042163","article-title":"Current understanding of immune thrombocytopenia: A review of pathogenesis and treatment options","volume":"25","author":"Mititelu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41423-023-01089-8","article-title":"MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages","volume":"20","author":"Cao","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","article-title":"Tissue macrophages: Origin, heterogenity, biological functions, diseases and therapeutic targets","volume":"10","author":"Guan","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R9-20260915","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000574","article-title":"Immune thrombocytopenia: Recent advances in pathogenesis and treatments","volume":"5","author":"Audia","year":"2021","journal-title":"Hemasphere"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cei.12935","article-title":"Fc\u03b3 receptor expression on splenic macrophages in adult immune thrombocytopenia","volume":"188","author":"Audia","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-immunol-101320-031555","article-title":"Functional hallmarks of healthy macrophage responses: Their regulatory basis and disease relevance","volume":"40","author":"Sheu","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41423-025-01268-9","article-title":"Targeting macrophage polarization by inhibiting Pim2 alleviates inflammatory arthritis via metabolic reprogramming","volume":"22","author":"Xu","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.tcb.2020.09.006","article-title":"Lipid metabolism in regulation of macrophage functions","volume":"30","author":"Yan","year":"2020","journal-title":"Trends Cell Biol"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1097\/CM9.0000000000003586","article-title":"Itaconate derivative 4-OI inhibits M1 macrophage polarization and restores its impaired function in immune thrombocytopenia through metabolic reprogramming","volume":"138","author":"Liu","year":"2025","journal-title":"Chin Med J"},{"key":"R16-20260915","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1394108","article-title":"Macrophage polarization in rheumatoid arthritis: Signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Immunol"},{"key":"R17-20260915","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/8821610","article-title":"Regulatory mechanism of M1\/M2 macrophage polarization in the development of autoimmune diseases","volume":"2023","author":"Peng","year":"2023","journal-title":"Mediators Inflamm"},{"key":"R18-20260915","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734008","article-title":"Macrophage polarization and plasticity in systemic lupus erythematosus","volume":"12","author":"Ahamada","year":"2021","journal-title":"Front Immunol"},{"key":"R19-20260915","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113058","article-title":"Potential mechanisms of rheumatoid arthritis therapy: Focus on macrophage polarization","volume":"142","author":"Yang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2021.11.019","article-title":"M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization","volume":"341","author":"Li","year":"2022","journal-title":"J Control Release"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/jth.13767","article-title":"High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia","volume":"15","author":"Feng","year":"2017","journal-title":"J Thromb Haemost"},{"key":"R22-20260915","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118569","article-title":"Phospholipid-derived lysophospholipids in (patho)physiology","volume":"398","author":"Prabutzki","year":"2024","journal-title":"Atherosclerosis"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/biom15020182","article-title":"Possible involvement of lysophospholipids in severe asthma as novel lipid mediators","volume":"15","author":"Kume","year":"2025","journal-title":"Biomolecules"},{"key":"R24-20260915","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158274","article-title":"Lysophosphatidylcholine: Potential target for the treatment of chronic pain","volume":"23","author":"Ren","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R25-20260915","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117443","article-title":"The mechanisms of lysophosphatidylcholine in the development of diseases","volume":"247","author":"Liu","year":"2020","journal-title":"Life Sci"},{"key":"R26-20260915","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.941914","article-title":"Lysophosphatidylcholine alleviates acute lung injury by regulating neutrophil motility and neutrophil extracellular trap formation","volume":"10","author":"Jeong","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4196\/kjpp.2022.26.3.175","article-title":"Lysophosphatidylcholine induces azurophil granule translocation via Rho\/Rho kinase\/F-actin polymerization in human neutrophils","volume":"26","author":"Ham","year":"2022","journal-title":"Korean J Physiol Pharmacol"},{"key":"R28-20260915","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.intimp.2016.07.014","article-title":"Stearoyl lysophosphatidylcholine enhances the phagocytic ability of macrophages through the AMP-activated protein kinase\/p38 mitogen activated protein kinase pathway","volume":"39","author":"Quan","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1182\/blood-2004-05-1916","article-title":"Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A","volume":"105","author":"Yang","year":"2005","journal-title":"Blood"},{"key":"R31-20260915","article-title":"Methyltransferase Setd2 prevents T cell-mediated autoimmune diseases via phospholipid remodeling","volume":"121","author":"Chen","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.31738","article-title":"Dysregulation of the lysophosphatidylcholine\/autotaxin\/lysophosphatidic acid axis in acute-on-chronic liver failure is associated with mortality and systemic inflammation by lysophosphatidic acid-dependent monocyte activation","volume":"74","author":"Trovato","year":"2021","journal-title":"Hepatology"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1007\/s10753-024-01986-8","article-title":"Relationship between the lipidome profile and disease activity in patients with rheumatoid arthritis","volume":"47","author":"Masuoka","year":"2024","journal-title":"Inflammation"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2015.08.028","article-title":"The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis","volume":"765","author":"Orosa","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"R35-20260915","article-title":"Acid sensing to inflammaging: Mechanisms and therapeutic promise of GPR68 (OGR1) in aging-related diseases","volume":"6","author":"Liu","year":"2025","journal-title":"Front Aging"},{"key":"R36-20260915","doi-asserted-by":"crossref","DOI":"10.3390\/genes15091151","article-title":"The roles of proton-sensing G-protein-coupled receptors in inflammation and cancer","volume":"15","author":"Justus","year":"2024","journal-title":"Genes (Basel)"},{"key":"R37-20260915","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101671","article-title":"GPR68, a proton-sensing GPCR, mediates acid-induced visceral nociception","volume":"20","author":"Paine","year":"2026","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R38-20260915","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/s41467-021-23050-x","article-title":"Alteration of circadian machinery in monocytes underlies chronic kidney disease-associated cardiac inflammation and fibrosis","volume":"12","author":"Yoshida","year":"2021","journal-title":"Nat Commun"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert","year":"2017","journal-title":"Blood"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41423-022-00859-0","article-title":"Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia","volume":"19","author":"Hou","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2010-07-295477","article-title":"High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia","volume":"117","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1007017509008","article-title":"Effects of atorvastatin treatment on the oxidatively modified low density lipoprotein in hyperlipidemic patients","volume":"207","author":"Zhu","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"R43-20260915","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10571-025-01566-w","article-title":"Atorvastatin protects against the macrophage\/microglia-related neuroinflammation via inhibiting lipocalin-2 in mouse experimental intracerebral hemorrhage model","volume":"45","author":"Wang","year":"2025","journal-title":"Cell Mol Neurobiol"},{"key":"R44-20260915","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): Double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"R45-20260915","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.151908","article-title":"Atorvastatin inhibits IL-17A, TNF, IL-6, and IL-10 in PBMC cultures from patients with severe rheumatoid arthritis","volume":"225","author":"de Oliveira","year":"2020","journal-title":"Immunobiology"},{"key":"R46-20260915","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"R47-20260915","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1344","article-title":"Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPAR\u03b3 promoter","volume":"13","author":"Shao","year":"2023","journal-title":"Clin Transl Med"},{"key":"R48-20260915","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/bjh.15452","article-title":"An unbalanced monocyte macrophage polarization in the bone marrow microenvironment of patients with poor graft function after allogeneic haematopoietic stem cell transplantation","volume":"182","author":"Zhao","year":"2018","journal-title":"Br J Haematol"},{"key":"R49-20260915","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24573","article-title":"Role of IL-10 and IL-22 cytokines in patients with primary immune thrombocytopenia and their clinical significance","volume":"36","author":"Liu","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"R50-20260915","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1751-553X.2011.01320.x","article-title":"Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients","volume":"33","author":"Saitoh","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"R51-20260915","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/bjh.17938","article-title":"Atorvastatin restores imbalance of cluster of differentiation 4 (CD4)+ T cells in immune thrombocytopenia in vivo and in vitro","volume":"201","author":"Xu","year":"2023","journal-title":"Br J Haematol"},{"key":"R52-20260915","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1182\/blood-2017-09-807248","article-title":"Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients","volume":"131","author":"Kong","year":"2018","journal-title":"Blood"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000004172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:00:18Z","timestamp":1789444818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000004172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":52,"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000004172","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"2025-08-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}